期刊文献+

The Influence of IFN-α on Blood Plasmacytoid Dendritic Cell in Chronic Myeloid Leukaemia

The Influence of IFN-α on Blood Plasmacytoid Dendritic Cell in Chronic Myeloid Leukaemia
下载PDF
导出
摘要 OBJECTIVE To study the mechanism of IFN on CML.METHODS Samples of 15 CML patients and 10 healthy controlswere studied. The flow cytometry was performed to identifycirculating pDCs. The concentration of IFN-α in serum and that inthe supernatant of peripheral blood mononuclear cells (PBMCs)cultured after stimulation with CpG ODN2216 were examinedboth in CML patients and in the healthy controlsRESULTS There was significant reduction in the numberof circulating pDCs, serum concentration of IFN-α and thecapacity of IFN-α producing PBMCs in CML patients comparedwith those in healthy control individuals (P < 0.001). After theactive treatment with IFN-α and hydroxyurea, the quantity andfunction of pDCs were increased in stabilized patients, especiallythe function of pDCs in 2 patients achieving major cytogeneticresponse (MCR). The proportion and function of pDCs and theserum levels of IFN were inversely correlated with both WBC andage of the patients with CML, and positively correlated with thestate of the illness.CONCLUSION CML patients had a reduced number anddysfunction of circulating pDCs. The active treatment with IFN inCML patients may be related to the restoration of pDCs. OBJECTIVE To study the mechanism of IFN on CML. METHODS Samples of 15 CML patients and 10 healthy controls were studied. The flow cytometry was performed to identify circulating pDCs. The concentration of IFN-α in serum and that in the supernatant of peripheral blood mononuclear cells (PBMCs) cultured after stimulation with CpG ODN2216 were examined both in CML patients and in the healthy controls RESULTS There was significant reduction in the number of circulating pDCs, serum concentration of IFN-α and the capacity of IFN-α producing PBMCs in CML patients compared with those in healthy control individuals (P 〈 0.001). After the active treatment with IFN-α and hydroxyurea, the quantity and function of pDCs were increased in stabilized patients, especially the function of pDCs in 2 patients achieving major cytogenetic response (MCR). The proportion and function of pDCs and the serum levels of IFN were inversely correlated with both WBC and age of the patients with CML, and positively correlated with the state of the illness. CONCLUSION CML patients had a reduced number and dysfunction of circulating pDCs. The active treatment with IFN in CML patients may be related to the restoration of pDCs.
出处 《Chinese Journal of Clinical Oncology》 CSCD 2009年第2期113-116,共4页 中国肿瘤临床(英文版)
基金 supported by a grant from the Science and Technology Planning Project of Gansu Province,China(No.2005LZ0627).
  • 相关文献

参考文献11

  • 1M. Copland,A. R. Fraser,S. J. Harrison,T. L. Holyoake.Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia[J].Cancer Immunology Immunotherapy.2005(4)
  • 2Deininger MWN,Goldman JM,Melo JV.The molecular biology of chronic myeloid leukemia[].Blood.2000
  • 3Dzionek A,Fuchs A,Soumidt P,et al.BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood[].The Journal of Immunology.2000
  • 4Bhatia R,Holtz M,Niu N,et al.Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment[].Blood.2003
  • 5H.M. Kantarjian,F.J. Giles,S. O’Brien.Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy[].Hematology Oncology Clinics of North America.1998
  • 6P. Rousselot,F. Huguet,D. Rea.Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years[].Blood.2007
  • 7Liu YJ.Professional type I interferon-producing cells and plasmacytoid dendritic cell precursors[].Annual Review of Immunology.2005
  • 8Pacanowski J,Kahi S,Baillet M,et al.Reduced blood CD123+ (lymphoid)and CD11c+ (myeloid)dendritic cell numbers in primary HIV1 infection[].Blood.2001
  • 9M. Lichtner,R. Rossi,F. Mengoni.Circulating dendritic cells and interferon-a production in patients with tuberculosis: Correlation with clinical outcome and treatment response[].Clin Experimen Immunol.2006
  • 10Bave U,Nordmark,G.Activation of the Type I Interferon System in Primary Sjogren’s Syndrome[].Arthritis and Rheumatism.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部